Ironwood Pharmaceuticals | IRWD - 市值



金融业
股票价格
USD
资产
USD 434.57M
现金及等价物
USD 220.47M
销售成本
USD 29.83M
流动资产
USD 332.29M
流动负债
USD 236.31M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.31
股本和储备
USD -217.14M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 640.2M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 113.04M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.24M
应收帐款人
USD 81.89M


市值 更改 日
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Akebia Therapeutics USD 427M 297M 2025-12
Almirall EUR 2.76B 472.53M 2025-12
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
Ardelyx USD 1.48B 63M 2026-03
Astellas Pharma JPY 3.94T 622.52B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Charles River Laboratories USD 10.39B 2.54B 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Incyte USD 22.65B 3.92B 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
MacroGenics USD 184M 82M 2026-03
Pacira USD 998M 83M 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Takeda JPY 8.2T 809.7B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vanda Pharmaceuticals USD 279M 6M 2024-12